RiverFront Investment Group’s Boston Scientific BSX Stock Holding History

RiverFront Investment Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	24,915 +3,607	+17%	+$289K	0.02%	158
2025 Q4	$2.03M	Buy	21,308 +150	+0.7%	+$14.7K	0.03%	122
2025 Q3	$2.07M	Buy	21,158 +15,254	+258%	+$1.58M	0.04%	116
2025 Q2	$634K	Buy	5,904 +524	+10%	+$53K	0.01%	184
2025 Q1	$543K	Buy	5,380 +1,799	+50%	+$181K	0.01%	184
2024 Q4	$320K	Buy	3,581 +561	+19%	+$49.4K	0.01%	197
2024 Q3	$253K	Buy	3,020 +141	+5%	+$11.1K	0.01%	190
2024 Q2	$222K	Buy	+2,879	New	+$211K	0.01%	157
2022 Q2	–	Sell	-5,136	Closed	-$227K	–	99
2022 Q1	$227K	Sell	5,136 -145	-3%	-$6.28K	0.01%	97
2021 Q4	$224K	Sell	5,281 -116,420	-96%	-$4.89M	0.01%	93
2021 Q3	$5.28M	Sell	121,701 -128,341	-51%	-$5.68M	0.18%	50
2021 Q2	$10.7M	Sell	250,042 -834	-0.3%	-$35.1K	0.22%	52
2021 Q1	$9.7M	Buy	250,876 +8,582	+4%	+$325K	0.2%	55
2020 Q4	$8.71M	Buy	+242,294	New	+$8.73M	0.19%	57

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

RiverFront Investment Group's BSX Position: Q1 2026 in Review

RiverFront Investment Group increased its Boston Scientific (BSX) stake by 17% in Q1 2026, buying an estimated $289K and bringing the position to 24,915 shares worth $1.56M. The position accounts for 0.02% of the portfolio, ranked #158.

RiverFront Investment Group first reported a position in BSX in Q4 2020 and has held it in 14 quarters since. The position peaked at $10.7M in Q2 2021. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

RiverFront Investment Group held 24,915 shares of Boston Scientific worth $1.56M as of Q1 2026.
RiverFront Investment Group bought 3,607 Boston Scientific shares in Q1 2026, an estimated $289K.
Boston Scientific made up 0.02% of RiverFront Investment Group's portfolio in Q1 2026, its #158 holding.
RiverFront Investment Group first reported a position in Boston Scientific in Q4 2020 and has held it in 14 quarters since.
RiverFront Investment Group's Boston Scientific position peaked at $10.7M in Q2 2021.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on RiverFront Investment Group's 13F filing for Q1 2026, filed 11 May 2026.